182 related articles for article (PubMed ID: 28748755)
1. Biotin and Glutathione Targeting of Solid Nanoparticles to Cross Human Brain Endothelial Cells.
Veszelka S; Meszaros M; Kiss L; Kota Z; Pali T; Hoyk Z; Bozso Z; Fulop L; Toth A; Rakhely G; Deli MA
Curr Pharm Des; 2017; 23(28):4198-4205. PubMed ID: 28748755
[TBL] [Abstract][Full Text] [Related]
2. Major involvement of Na(+) -dependent multivitamin transporter (SLC5A6/SMVT) in uptake of biotin and pantothenic acid by human brain capillary endothelial cells.
Uchida Y; Ito K; Ohtsuki S; Kubo Y; Suzuki T; Terasaki T
J Neurochem; 2015 Jul; 134(1):97-112. PubMed ID: 25809983
[TBL] [Abstract][Full Text] [Related]
3. Niosomes decorated with dual ligands targeting brain endothelial transporters increase cargo penetration across the blood-brain barrier.
Mészáros M; Porkoláb G; Kiss L; Pilbat AM; Kóta Z; Kupihár Z; Kéri A; Galbács G; Siklós L; Tóth A; Fülöp L; Csete M; Sipos Á; Hülper P; Sipos P; Páli T; Rákhely G; Szabó-Révész P; Deli MA; Veszelka S
Eur J Pharm Sci; 2018 Oct; 123():228-240. PubMed ID: 30031862
[TBL] [Abstract][Full Text] [Related]
4. Uptake and permeability studies of BBB-targeting immunoliposomes using the hCMEC/D3 cell line.
Markoutsa E; Pampalakis G; Niarakis A; Romero IA; Weksler B; Couraud PO; Antimisiaris SG
Eur J Pharm Biopharm; 2011 Feb; 77(2):265-74. PubMed ID: 21118722
[TBL] [Abstract][Full Text] [Related]
5. Solid lipid nanoparticles as a vehicle for brain-targeted drug delivery: two new strategies of functionalization with apolipoprotein E.
Neves AR; Queiroz JF; Weksler B; Romero IA; Couraud PO; Reis S
Nanotechnology; 2015 Dec; 26(49):495103. PubMed ID: 26574295
[TBL] [Abstract][Full Text] [Related]
6. The blood-brain barrier sodium-dependent multivitamin transporter: a molecular functional in vitro-in situ correlation.
Park S; Sinko PJ
Drug Metab Dispos; 2005 Oct; 33(10):1547-54. PubMed ID: 16033951
[TBL] [Abstract][Full Text] [Related]
7. Anti-Aβ-MAb and dually decorated nanoliposomes: effect of Aβ1-42 peptides on interaction with hCMEC/D3 cells.
Markoutsa E; Papadia K; Clemente C; Flores O; Antimisiaris SG
Eur J Pharm Biopharm; 2012 May; 81(1):49-56. PubMed ID: 22386910
[TBL] [Abstract][Full Text] [Related]
8. An in vitro and in vivo study of peptide-functionalized nanoparticles for brain targeting: The importance of selective blood-brain barrier uptake.
Bode GH; Coué G; Freese C; Pickl KE; Sanchez-Purrà M; Albaiges B; Borrós S; van Winden EC; Tziveleka LA; Sideratou Z; Engbersen JFJ; Singh S; Albrecht K; Groll J; Möller M; Pötgens AJG; Schmitz C; Fröhlich E; Grandfils C; Sinner FM; Kirkpatrick CJ; Steinbusch HWM; Frank HG; Unger RE; Martinez-Martinez P
Nanomedicine; 2017 Apr; 13(3):1289-1300. PubMed ID: 27884636
[TBL] [Abstract][Full Text] [Related]
9. Reduction in cardiolipin decreases mitochondrial spare respiratory capacity and increases glucose transport into and across human brain cerebral microvascular endothelial cells.
Nguyen HM; Mejia EM; Chang W; Wang Y; Watson E; On N; Miller DW; Hatch GM
J Neurochem; 2016 Oct; 139(1):68-80. PubMed ID: 27470495
[TBL] [Abstract][Full Text] [Related]
10. Optically Manipulated Microtools to Measure Adhesion of the Nanoparticle-Targeting Ligand Glutathione to Brain Endothelial Cells.
Fekete T; Mészáros M; Szegletes Z; Vizsnyiczai G; Zimányi L; Deli MA; Veszelka S; Kelemen L
ACS Appl Mater Interfaces; 2021 Aug; 13(33):39018-39029. PubMed ID: 34397215
[TBL] [Abstract][Full Text] [Related]
11. Quantitative targeted absolute proteomic analysis of transporters, receptors and junction proteins for validation of human cerebral microvascular endothelial cell line hCMEC/D3 as a human blood-brain barrier model.
Ohtsuki S; Ikeda C; Uchida Y; Sakamoto Y; Miller F; Glacial F; Decleves X; Scherrmann JM; Couraud PO; Kubo Y; Tachikawa M; Terasaki T
Mol Pharm; 2013 Jan; 10(1):289-96. PubMed ID: 23137377
[TBL] [Abstract][Full Text] [Related]
12. A filter-free blood-brain barrier model to quantitatively study transendothelial delivery of nanoparticles by fluorescence spectroscopy.
De Jong E; Williams DS; Abdelmohsen LKEA; Van Hest JCM; Zuhorn IS
J Control Release; 2018 Nov; 289():14-22. PubMed ID: 30243824
[TBL] [Abstract][Full Text] [Related]
13. The endo-lysosomal system of bEnd.3 and hCMEC/D3 brain endothelial cells.
Toth AE; Nielsen SSE; Tomaka W; Abbott NJ; Nielsen MS
Fluids Barriers CNS; 2019 May; 16(1):14. PubMed ID: 31142333
[TBL] [Abstract][Full Text] [Related]
14. Solid lipid nanoparticles for delivery of andrographolide across the blood-brain barrier: in vitro and in vivo evaluation.
Graverini G; Piazzini V; Landucci E; Pantano D; Nardiello P; Casamenti F; Pellegrini-Giampietro DE; Bilia AR; Bergonzi MC
Colloids Surf B Biointerfaces; 2018 Jan; 161():302-313. PubMed ID: 29096375
[TBL] [Abstract][Full Text] [Related]
15. Crossing the blood-brain barrier: Glutathione-conjugated poly(ethylene imine) for gene delivery.
Englert C; Trützschler AK; Raasch M; Bus T; Borchers P; Mosig AS; Traeger A; Schubert US
J Control Release; 2016 Nov; 241():1-14. PubMed ID: 27586188
[TBL] [Abstract][Full Text] [Related]
16. Glutathione conjugation dose-dependently increases brain-specific liposomal drug delivery in vitro and in vivo.
Maussang D; Rip J; van Kregten J; van den Heuvel A; van der Pol S; van der Boom B; Reijerkerk A; Chen L; de Boer M; Gaillard P; de Vries H
Drug Discov Today Technol; 2016 Jun; 20():59-69. PubMed ID: 27986226
[TBL] [Abstract][Full Text] [Related]
17. Functionalization of liposomes with ApoE-derived peptides at different density affects cellular uptake and drug transport across a blood-brain barrier model.
Re F; Cambianica I; Zona C; Sesana S; Gregori M; Rigolio R; La Ferla B; Nicotra F; Forloni G; Cagnotto A; Salmona M; Masserini M; Sancini G
Nanomedicine; 2011 Oct; 7(5):551-9. PubMed ID: 21658472
[TBL] [Abstract][Full Text] [Related]
18. Memantine transport by a proton-coupled organic cation antiporter in hCMEC/D3 cells, an in vitro human blood-brain barrier model.
Higuchi K; Kitamura A; Okura T; Deguchi Y
Drug Metab Pharmacokinet; 2015 Apr; 30(2):182-7. PubMed ID: 25857234
[TBL] [Abstract][Full Text] [Related]
19. Targeting nanoparticles to the brain by exploiting the blood-brain barrier impermeability to selectively label the brain endothelium.
Gonzalez-Carter D; Liu X; Tockary TA; Dirisala A; Toh K; Anraku Y; Kataoka K
Proc Natl Acad Sci U S A; 2020 Aug; 117(32):19141-19150. PubMed ID: 32703811
[TBL] [Abstract][Full Text] [Related]
20. Binding, transcytosis and biodistribution of anti-PECAM-1 iron oxide nanoparticles for brain-targeted delivery.
Dan M; Cochran DB; Yokel RA; Dziubla TD
PLoS One; 2013; 8(11):e81051. PubMed ID: 24278373
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
